Researchers at the University of Alabama at Birmingham will study individuals with genetic mutations associated with Parkinson’s disease as one of 32 clinical sites of the Parkinson’s Progression Markers Initiative (PPMI), a large-scale biomarker study sponsored by The Michael J. Fox Foundation for Parkinson’s Research.
PPMI will enroll participants with a known mutation of the LRRK or SNCA [alpha-synuclein] gene. Previous research has shown these mutations are associated with Parkinson’s disease and account for a greater number of PD cases among certain ethnic populations and families, notably the LRRK2 mutation in those of Ashkenazi (Eastern European) Jewish, Basque and North African Berber descent. The insight investigators glean from these research volunteers will fortify current efforts to develop a disease-modifying therapy, something that currently eludes the field.
“Studying individuals with genetic mutations associated with Parkinson’s can accelerate our research toward a PD biomarker and more effective treatments,” said David Standaert, M.D., Ph.D., chair of the Department of Neurology and primary investigator at UAB. “Although known genetic mutations account for only five to 10 percent of all Parkinson’s cases, this population can provide invaluable information about the intricacies of the disease for all patients.”
PPMI is studying clinical and imaging data and biological samples of people with a genetic mutation to identify biomarkers and speed clinical trials. PPMI will enroll 250 people with the LRRK2 mutation and Parkinson’s, and 250 people with the mutation but without Parkinson’s. Since the SNCA mutation is more rare, the study is recruiting 50 people with Parkinson’s and the mutation, and 50 people with the SNCA mutation but without PD. These participants will be followed for five years.
Interested individuals can visit www.michaeljfox.org/ppmi/genetics, call 877-836-8108 or e-mail firstname.lastname@example.org. PPMI is particularly interested in testing individuals of Ashkenazi (Eastern European) Jewish descent or their relatives with Parkinson’s. The LRRK2 mutation also accounts for more PD cases in people of North African Arab Berber or Basque descent. Study sites will recruit people with the rarer SNCA mutation through familial connections.
Biomarkers — such as cholesterol level for heart disease — are substances, processes or characteristics of the body that communicate disease risk, onset and/or progression. They aid in diagnosis and disease management and help researchers stratify for clinical trials and test new drugs more quickly by measuring biological changes rather than waiting for clinical improvement. There are no validated biomarkers for Parkinson’s disease, a reality researchers are hoping to change with PPMI.
Launched in 2010, PPMI is a longitudinal clinical study that collects standardized clinical, imaging and biologic data. Now taking place at 32 clinical sites around the world, the study completed initial enrollment of 423 recently diagnosed Parkinson’s patients and 196 controls in April 2013. That month, PPMI began recruiting individuals with the known Parkinson’s risk factors of smell loss and REM sleep behavior disorder.
“In the fourth year of PPMI, it is evident that a large-scale biomarker study is not only possible in Parkinson’s disease, but is already yielding scientific insights that could help transform the field of Parkinson’s research,” said Todd Sherer, Ph.D., CEO of The Michael J. Fox Foundation. “The exceptional investigators at sites around the world, such as at UAB, have created the infrastructure that allows us to make such strides, by working together.”
Educational forum for myelodysplastic syndromes patients and families set for June 25A workshop is set to provide information and resources for MDS patients and families June 25.posted 10 days ago 717 viewsIn-hospital mobility program proves successful for patients’ posthospital functionA UAB study in the Journal of the American Medical Association shows patients’ mobility while hospitalized helps maintain daily activity in older adults.posted 10 days ago 1958 viewsIn human clinical trial, UAB to test diet’s effect on ovarian cancer patientsMetabolism-based therapies such as the ketogenic diet have the potential to become a valuable adjunct to standard cancer treatment.posted 10 days ago 2671 viewsUAB to open institute for surgical outcomes research honoring John and James KirklinThe new Kirklin Institute for Research in Surgical Outcomes positions UAB as a world leader in improving patient outcomes.posted 15 days ago 5300 viewsUAB joins Lung Association Airways Clinical Research NetworkUAB’s Lung Health Center has joined the prestigious Airways Clinical Research Network established by the American Lung Association.posted 17 days ago 1083 viewsUAB receives cutting-edge robot to diagnose and support treatment of prostate cancerProstate cancer physicians look to provide personalized medicine to prostate cancer patients with a new medical device.posted 17 days ago 2046 viewsZika, pregnancy and microcephaly: What you need to knowA UAB physician provides information on risks, recommendations and effects of Zika virus for pregnant women.posted 22 days ago 4459 viewsNew implantable device available at UAB eases sleep apneaUAB is the first hospital in Alabama to implant a new electrical stimulator to combat sleep apnea and snoring.posted 22 days ago 3836 viewsFinding a primary care physician is an important step for millennialsUAB’s William Curry, M.D., explains the advantages for millennials to find a primary care physician and why it is a necessary step to take for their health.posted 22 days ago 1734 viewsUAB Medicine first in Alabama to publicly report cardiac services dataUAB is the first hospital in Alabama to participate in publicly reporting its data with American College of Cardiology’s Find Your Heart a Home pilot program.posted 24 days ago 1140 viewsUAB developing training program on Ebola for first responders in Deep SouthUAB has received a grant to develop and implement Ebola and infectious disease training to further protect health care and public safety workers.posted 24 days ago 1992 viewsUAB Comprehensive Cancer Center awarded $29 million NCI core grantThe UAB Cancer Center has received a $29 million National Cancer Institute renewal grant and is re-designated as “comprehensive” with an outstanding rating as a leader in advancing cancer research and care.posted a while back 2601 viewsBirmingham woman completes year in verapamil-diabetes clinical trialRecruitment for the trial continues as Myers discusses the benefits she received from participating and the knowledge she has gained to take control of her health care.posted a while back 3067 viewsNew study to address issue of low physical activity in African-AmericansSchool of Nursing Assistant Professor Pamela Bowen hopes to address the issue of physical activity in African-Americans in the South through a new study.posted a while back 2006 viewsS&P raises UAB bond ratings on very strong financial and enterprise profilesIdentifying a stable outlook and UAB’s very strong enterprise and financial profile, S&P Global Ratings has raised its rating on various series of general revenue bonds issued by The University of Alabama System Board of Trustees on behalf of UAB.posted a while back 1462 viewsBakitas honored for continued impact on palliative care fieldMarie Bakitas, DNSc, associate director and senior scientist at the UAB Center for Palliative and Supportive Care, was recently recognized for continued outstanding work in the palliative care field.posted a while back 1110 viewsMother-daughter team fights breast cancer professionally, personallyMadeline Harris and Kristen Noles centered their careers on caring for patients at UAB Hospital; now they celebrate five years of breast cancer survivorship for Noles.posted a while back 2213 viewsHIV vaccine design should adapt as HIV virus mutatesResearchers from UAB, Emory and Microsoft demonstrate that HIV has evolved to be pre-adapted to the immune response, worsening clinical outcomes in newly infected patients.posted a while back 3333 viewsUAB establishes Division of Congenital Cardiac AnesthesiologyThe new Division of Congenital Cardiac Anesthesiology represents a move to more fully align and integrate with other clinical divisions that provide care for congenital cardiac patients at Children’s of Alabama.posted a while back 858 viewsMore than 10 risk factors identified in readmission of pediatric neurosurgery patientsBig data provides insight into patient readmission after pediatric neurosurgery.posted a while back 2950 views